BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/28/2025 10:45:11 AM | Browse: 200 | Download: 712
 |
Received |
|
2024-08-20 06:21 |
 |
Peer-Review Started |
|
2024-09-06 00:47 |
 |
First Decision by Editorial Office Director |
|
2024-12-24 03:52 |
 |
Return for Revision |
|
2024-12-24 03:52 |
 |
Revised |
|
2024-12-30 02:36 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2025-01-10 02:35 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2025-01-10 07:27 |
 |
Articles in Press |
|
2025-01-10 07:27 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2025-01-31 08:03 |
 |
Publish the Manuscript Online |
|
2025-02-28 10:45 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Exploration of metformin-based drug combination for mitigating diabetes-associated atherosclerotic diseases
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Biao Qu, Zheng Li and Wei Hu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the Natural Science Research Project of Anhui Province |
2023AH053172 |
| National Natural Science Foundation of Anhui Province |
2408085QH260 |
| Projects of Administration of Traditional Chinese Medicine of Anhui Province |
2024CCCX082 |
| National Natural Science Foundation Incubation Program of The Second Hospital of Anhui Medical University |
2022GMFY08 |
|
| Corresponding Author |
Wei Hu, PhD, Professor, Department of Clinical Pharmacology, The Second Hospital of Anhui Medical University, No. 678 Furong Road, Hefei 230601, Anhui Province, China. huwei@ahmu.edu.cn |
| Key Words |
Diabetes; Atherosclerotic diseases; Metformin; Drug combination; Hypoglycemic agent; Hypolipidemic agent; Antioxidant agent |
| Core Tip |
The hyperglycemic state can actually induce atherosclerosis development or further accelerate its progression, which leads to cardio-cerebrovascular diseases associated with high morbidity and mortality. As metformin is the preferred first-line drug to manage type 2 diabetes, metformin combined with either hypoglycemic agents, hypolipidemic agents, or systemic antioxidant/anti-inflammatory agents, have been investigated to provide additional vascular benefits. It is quite clear that such exploration can contribute to finding a better drug combination to mitigate diabetes-associated atherosclerotic diseases. |
| Publish Date |
2025-02-28 10:45 |
| Citation |
Qu B, Li Z, Hu W. Exploration of metformin-based drug combination for mitigating diabetes-associated atherosclerotic diseases. World J Diabetes 2025; 16(4): 100533
|
| URL |
https://www.wjgnet.com/1948-9358/full/v16/i4/100533.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v16.i4.100533 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.